Abstract
Background: The revised FIGO staging system for carcinoma of the vulva, cervix uteri, and endometrium, which had been previously revised in 1988, 1994, and 1988, respectively, was approved by the International Federation of Gynecology and Obstetrics (FIGO) in September 2008. In addition to the revisions of previously existing staging systems, a new staging system for uterine sarcomas was introduced at the same time. Conclusions: The changes mostly addressed the prognostic disproportions between certain (sub) stages that had been shown in numerous statistical analyses. Vulvar cancer staging has undergone the greatest changes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
